March 29, 2017 4:20 AM ET

Biotechnology

Company Overview of Labrys Biologics, Inc.

Key Executives for Labrys Biologics, Inc.

NameBoard RelationshipsTitleAge
Corey S. Goodman Ph.D.106 RelationshipsFounder and Chairman59
Marcelo Bigal M.D., Ph.D.No RelationshipsChief Medical Officer--
Michael Chang Ph.D.No RelationshipsVice President of Project Management--
Rafael Escandón Ph.D., MPHNo RelationshipsVice President of Clinical Operations--
Henry Stern No RelationshipsExecutive Director of CMC--

Labrys Biologics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Corey S. Goodman Ph.D. 106 RelationshipsSecond Genome, Inc.59
Wende S. Hutton MBA 64 RelationshipsCanaan Partners56
Nina S. Kjellson 80 RelationshipsCanaan Partners41
Michael F. Powell Ph.D. 88 RelationshipsSofinnova Ventures, Inc.61
Steven P. James 27 RelationshipsAntiva Biosciences, Inc.58
View All Board Members

Labrys Biologics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
320.0K
Bonus
244.2K
Total Short Term Compensation
406.1K
Total Value of Options
2.7M
Compensation as of Fiscal Year
Labrys Biologics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Threshold Pharmaceuticals, Inc. and Molecular Templates, Inc. Announce Executive Appointments to Combined Company
March 27, 2017 9:01 PM ET
Threshold Pharmaceuticals, Inc. and Molecular Templates, Inc. Announce Executive Appointments to Combined Company
March 27, 2017 9:01 PM ET
Coherus BioSciences, Inc. Appoints Erik Wiberg as Executive Vice President of Corporate Development
March 27, 2017 9:00 PM ET
Aquinox Pharmaceuticals, Inc. Announces Board Appointments
March 27, 2017 8:02 PM ET
Aptose Biosciences Inc. Announces Resignation of Avanish Vellanki as Senior Vice President and Chief Business Officer
March 27, 2017 1:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Labrys Biologics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.